v3.19.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Option Grants Valuation Assumptions

The relevant data used to determine the value of the stock option grants for employees and directors for the years ended December 31, 2018 and 2017 is as follows, presented on a weighted-average basis:

 

     Year Ended December 31,  
                     2018                                      2017                   

Risk-free interest rate

     2.79     2.03

Expected volatility

     49.66     47.00

Expected dividend yield

     0     0

Expected term (in years)

     5.73       6.08  
Schedule of Stock Options Activity

The following table summarizes the Company’s option activity since December 31, 2017:

 

         Number of Shares         Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Term
     Aggregate
Intrinsic
Value
 
                  (in years)      (in thousands)  

Outstanding as of December 31, 2017

                     3,535,560     $             4.74        7.30      $             8,895  

Granted

     1,342,840       10.40        

Exercised

     (601,018     1.43        

Forfeited

     (507,296     7.51        
  

 

 

         

Outstanding as of December 31, 2018

     3,770,086     $ 6.91        7.44      $ 1,956  
  

 

 

         

Vested and expected to vest as of December 31, 2018

     3,436,473     $ 6.70        7.34      $ 1,938  
  

 

 

         

Options exercisable as of December 31, 2018

     1,910,882     $ 4.90        6.36      $ 1,938  
  

 

 

         

Schedule of Unvested Restricted Stock Units

The following table summarizes the Company’s RSU activity since December 31, 2017:

 

         Number of Shares         Weighted Average
    Grant-Date Fair Value    
 

Unvested balance December 31, 2017

     242,496     $                             6.90  

Granted

     2,378,578       16.76  

Vested

     (208,081     14.40  

Forfeited

     (3,100     14.75  
  

 

 

   

Unvested balance December 31, 2018

                     2,409,893     $ 15.98  
  

 

 

   

 

Summary of Stock-Based Compensation Expense of Statements of Operations and Comprehensive Loss

The Company recorded stock-based compensation expense in the following expense categories of its statements of operations and comprehensive loss (in thousands):

 

     Year Ended December 31,  
                     2018                                       2017                   

Cost of revenue

   $ 42      $ 27  

Sales and marketing

     1,955        789  

Research and development

     2,011        467  

General and administrative

     3,113        577  
  

 

 

    

 

 

 
   $                     7,121      $                     1,860